English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ultratard (insulin human) – Conditions or restrictions regarding supply and use - A10AE01

Updated on site: 10-Oct-2017

Medication nameUltratard
ATC CodeA10AE01
Substanceinsulin human
ManufacturerNovo Nordisk A/S

Article Contents

A MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE

Name and address of the manufacturer of the biological active substance

authorised

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsvaerd

Denmark

Name and address of the manufacturers responsible for batch release

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsvaerd

Denmark

B CONDITIONS OF THE MARKETING AUTHORISATION

 

CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON THE MARKETING AUTHORISATION HOLDER

Medicinal product subject to medical prescription

OTHER CONDITIONS

 

 

no

The holder of this marketing authorisation must inform the European Commission about the marketing

plans for the medicinal product authorised by this decision.

Medicinal

Product

 

 

 

Comments

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Help
  • Get it on Google Play
  • About
  • Info on site by:

  • Presented by RXed.eu

  • 27558

    prescription drugs listed